New in the #RedJournal: Patient reported outcomes following MR-guided radiotherapy for prostate cancer: A systematic review and meta-analysis. #radonc@jmwesterhoff @LoisDaamen https://t.co/DRCfmi95aI
Online adaptive magnetic resonance-guided radiotherapy is associated with a low risk of high-grade acute toxic effects, this study finds. @MOMENTUM_study https://t.co/4WKlue5Nez
The latest @MOMENTUM_study results are in! Data on 1.8k patients show acute, severe toxicity is uncommon. And, in a subset of ~1k patients treated using the full online adaptive workflow, just 0.4% experienced grade 3 toxicity. Read more from @jmwesterhoff https://t.co/uqfLyUszFd
At #ESTRO? If so, please join Jasmijn Westerhoff as she presents “The patterns of care and safety in 1800 patients treated on a high-field MR-Linac platform registry”. Sunday, 8 May 2022 at 10:30am, room D4. #MOMENTUM#learnfromeverypatient
As part of a worldwide radiotherapy trial using the MR-linac, Barry Staniforth has become the UK’s first lung cancer patient to benefit from a state-of-art radiotherapy treatment at The Christie.
Read more 👉 https://t.co/Sj8N6otrx3